ArticleScientific reports2026
Informed spatially aware patterns for multiplexed immunofluorescence data.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- ISPAT-3D: Spatially Varying Conditional Volumetric Network Estimation for 3D Tumor Imaging.Research square · 2026Article
- ISPAT-3D: Spatially Varying Conditional Volumetric Network Estimation for 3D Tumor Imaging.bioRxiv : the preprint server for biology · 2026Article
- Spatially Varying Graphical Models for Cell-Cell Interaction Networks in Multiplexed Tissue Imaging.bioRxiv : the preprint server for biology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Multiplexed immunofluorescence (mIF) imaging has revolutionized the study of cellular interactions within tissue microenvironments, enabling complex pattern analysis critical to understanding disease biology. However, current analytical methods assume uniform cellular patterns across tissues, overlooking the spatial heterogeneity that characterizes tumor microenvironments. Here, we introduce ISPat (Informed Spatially aware Patterns), a fully Bayesian framework that identifies both shared and region-specific interaction patterns while integrating domain knowledge to enhance spatial pattern estimation. ISPat models spatial cellular densities through kernel density estimation, then constructs interaction networks from precision matrices that capture conditional dependencies between cell types while controlling for confounding effects. The resulting networks reveal direct cellular relationships, with non-zero precision matrix entries indicating significant interactions. We applied ISPat to analyze 119 pancreatic ductal adenocarcinoma (PDAC) and 53 intraductal papillary mucinous neoplasm (IPMN) patients, partitioning tissues into five regions based on tumor intensity gradients. Our analysis revealed fundamentally distinct immune architectures: PDAC maintains a rigid, stable immunosuppressive microenvironment across tumor heterogeneity gradients, whereas IPMN exhibits dynamic spatial remodeling with marked regional variability. Critically, we identified multiple ligand-receptor (LR) interactions that consistently differ between disease conditions specifically in intermediate tumor intensity regions, while extreme conditions showed no significant differences. These include interactions spanning multiple functional axes of anti-tumor immunity: antigen presentation and T cell activation (APC↔CTL, THelper↔APC, Epithelial↔APC), effector function and tumor cell killing (Epithelial↔CTL, CTL↔Treg), and immune regulation (Epithelial↔Treg, Treg↔APC, THelper↔Treg). Notably, the APC↔CTL interaction, fundamental for adaptive immunity activation, differs significantly in high tumor density regions, alongside Epithelial↔CTL interactions critical for direct tumor elimination. These spatially resolved signatures provide quantitative evidence for distinct immune evasion mechanisms and represent promising biomarker candidates for disease classification and risk stratification. Through simulation studies, we demonstrated ISPat's accuracy in pattern recovery and its computational efficiency, achieving 8-10 fold speedup over comparable methods through variational Bayesian inference. The framework exhibits robust scalability and handles naturally occurring partition size imbalances, making it well-suited for analyzing heterogeneous tissues. Our findings demonstrate that spatial context fundamentally shapes cellular interactions in pancreatic cancer, with critical implications for understanding immune evasion mechanisms and developing spatially informed therapeutic strategies. The identification of differential interactions across antigen presentation, effector function, and immune regulation pathways suggests that therapeutic interventions must address multiple axes of immune dysfunction rather than single targets. ISPat provides a generalizable framework for spatial analysis applicable to emerging technologies, enabling precision oncology approaches guided by spatially resolved biomarkers.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.